Trial Profile
Ramelteon for Treatment of Adult Patients With ADHD [attention-deficit hyperactivity disorder]-Related Insomnia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jun 2013
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary)
- Indications Attention-deficit hyperactivity disorder; Insomnia
- Focus Therapeutic Use
- 25 Jan 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 25 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Feb 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.